The Swiss national drug regulatory agency Swissmedic
has released an updated version of their "Questions & Answers of
Swissmedic eCTD Implementation". The Q&A document "aims to address
the commonly-asked questions and provide guidance on Swissmedic's plans
to implement electronic-only submissions with eCTD".
The Q&A is intended to be a "living" document,
thus Swissmedic encourages applicants, other regulators, consultants and
vendors to give feedback.
The new version of the Q & A document (clean and Marked) avilable in the below mentioned weblink
No comments:
Post a Comment